Medpace Holdings Inc (MEDP)
389.77
-7.79
(-1.96%)
USD |
NASDAQ |
Apr 25, 16:00
389.32
-0.45
(-0.12%)
After-Hours: 20:00
Medpace Holdings Total Assets (Quarterly): 1.796B for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 1.796B |
| December 31, 2023 | 1.657B |
| September 30, 2023 | 1.487B |
| June 30, 2023 | 1.407B |
| March 31, 2023 | 1.396B |
| December 31, 2022 | 1.352B |
| September 30, 2022 | 1.328B |
| June 30, 2022 | 1.315B |
| March 31, 2022 | 1.344B |
| December 31, 2021 | 1.660B |
| September 30, 2021 | 1.577B |
| June 30, 2021 | 1.470B |
| March 31, 2021 | 1.451B |
| December 31, 2020 | 1.391B |
| September 30, 2020 | 1.296B |
| June 30, 2020 | 1.222B |
| March 31, 2020 | 1.138B |
| Date | Value |
|---|---|
| December 31, 2019 | 1.143B |
| September 30, 2019 | 1.072B |
| June 30, 2019 | 1.017B |
| March 31, 2019 | 1.007B |
| December 31, 2018 | 967.93M |
| September 30, 2018 | 949.84M |
| June 30, 2018 | 968.18M |
| March 31, 2018 | 973.02M |
| December 31, 2017 | 950.72M |
| September 30, 2017 | 948.88M |
| June 30, 2017 | 963.65M |
| March 31, 2017 | 966.09M |
| December 31, 2016 | 979.10M |
| September 30, 2016 | 976.49M |
| June 30, 2016 | 994.86M |
| March 31, 2016 | 994.00M |
| December 31, 2015 | 984.04M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
1.017B
Minimum
Jun 2019
1.796B
Maximum
Mar 2024
1.376B
Average
1.372B
Median
Total Assets (Quarterly) Benchmarks
| Charles River Laboratories International Inc | 8.195B |
| Avid Bioservices Inc | 455.23M |
| Iovance Biotherapeutics Inc | 780.35M |
| Renovaro Inc | 58.02M |
| Candel Therapeutics Inc | 41.20M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 1.124B |
| Shareholders Equity (Quarterly) | 671.54M |
| Current Ratio | 0.7787 |
| Net Debt Paydown Yield | 0.08% |